Ronglai Shen

发表

Abstract CT118: Efficient basket trial designs

Kristen M. Cunanan, Alexia Iasonos, Ronglai Shen, 2016 .

Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis

Adam B. Olshen, Ronglai Shen, Marc Ladanyi, 2009, Bioinform..

Internet-based profiler system as integrative framework to support translational research

Alberto Riva, Ronglai Shen, Robert Kim, 2005, BMC Bioinformatics.

Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis

Adam B. Olshen, Ronglai Shen, Marc Ladanyi, 2009, Bioinform..

Using association signal annotations to boost similarity network fusion

Shuang Wang, Ronglai Shen, Peifeng Ruan, 2019, Bioinform..

SPARSE INTEGRATIVE CLUSTERING OF MULTIPLE OMICS DATA SETS.

Sijian Wang, Ronglai Shen, Qianxing Mo, 2013, The annals of applied statistics.

Modeling intra‐tumor protein expression heterogeneity in tissue microarray experiments

Debashis Ghosh, Jeremy M G Taylor, Ronglai Shen, 2008, Statistics in medicine.

Variance prior specification for a basket trial design using Bayesian hierarchical modeling

Mithat Gönen, Kristen M Cunanan, Alexia Iasonos, 2019, Clinical trials.

Specifying the True- and False-Positive Rates in Basket Trials.

Mithat Gönen, Kristen M Cunanan, Alexia Iasonos, 2017, JCO precision oncology.

Using the “Hidden” genome to improve classification of cancer types

Ronglai Shen, Colin B. Begg, Saptarshi Chakraborty, 2020, Biometrics.

Eigengene-based linear discriminant model for tumor classification using gene expression microarray data

Debashis Ghosh, Ronglai Shen, Arul M. Chinnaiyan, 2006, Bioinform..

A Latent Variable Approach for Integrative Clustering of Multiple Genomic Data Types

Debashis Ghosh, George C. Tseng, Ronglai Shen, 2015 .

Reconstructing tumor-wise protein expression in tissue microarray studies using a Bayesian cell mixture model

Debashis Ghosh, Ronglai Shen, Jeremy M. G. Taylor, 2008, Bioinform..

A Latent Variable Approach for Meta-Analysis of Gene Expression Data from Multiple Microarray Experiments

Hyungwon Choi, Debashis Ghosh, Ronglai Shen, 2007, BMC Bioinformatics.

A fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data.

Marina Vannucci, Cui Guo, Ronglai Shen, 2018, Biostatistics.

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

Debashis Ghosh, Ronglai Shen, Daniel F. Hayes, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data

Debashis Ghosh, Ronglai Shen, Arul M Chinnaiyan, 2004, BMC Genomics.

An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma.

Chris Sander, Augustin Luna, Ed Reznik, 2016, Cancer cell.

Pathway analysis reveals functional convergence of gene expression profiles in breast cancer

Debashis Ghosh, Ronglai Shen, Arul M Chinnaiyan, 2008 .

Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.

Ahmet Zehir, Ronglai Shen, Barry S Taylor, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genomic investigation of etiologic heterogeneity: methodologic challenges

Jose A Karam, Ronglai Shen, Colin B Begg, 2014, BMC Medical Research Methodology.

High Expression Levels of Total IGF-1R and Sensitivity of NSCLC Cells In Vitro to an Anti-IGF-1R Antibody (R1507)

William Pao, Martin Peifer, Ronglai Shen, 2009, PloS one.

Autoantibody signatures in prostate cancer.

Debashis Ghosh, Ronglai Shen, Arul M Chinnaiyan, 2005, The New England journal of medicine.

Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer.

William Pao, Jason A Koutcher, Ronglai Shen, 2009, The Journal of clinical investigation.

Molecular Characteristics Predict Clinical Outcomes: Prospective Trial Correlating Response to the EGFR Tyrosine Kinase Inhibitor Gefitinib with the Presence of Sensitizing Mutations in the Tyrosine Binding Domain of the EGFR Gene

William Pao, Ronglai Shen, Marc Ladanyi, 2011, Clinical Cancer Research.

Statistical Methods in Cancer Genomics.

Ronglai Shen, R. Shen, R. Shen, 2007 .

Integrating Clinical and Multiple Omics Data for Prognostic Assessment across Human Cancers

Debashis Ghosh, Bin Zhu, Hongyu Zhao, 2017, Scientific Reports.

Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers

Ronglai Shen, Marc Ladanyi, M. Ladanyi, 2012, Clinical Cancer Research.

The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers.

Rui Bi, Ronglai Shen, Nadeem Riaz, 2018, Journal of the National Cancer Institute.

Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer

Debashis Ghosh, Lei Wang, Ronglai Shen, 2007, Modern Pathology.

An efficient basket trial design

Mithat Gönen, Alexia Iasonos, Ronglai Shen, 2017, Statistics in medicine.

Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway.

Ronglai Shen, Jorge S. Reis-Filho, Nikolaus Schultz, 2018, Cancer cell.

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer

Peter W. Laird, Joshua M. Stuart, Rehan Akbani, 2018, Cell.

Time to Recurrence and Survival in Serous Ovarian Tumors Predicted from Integrated Genomic Profiles

Chris Sander, Ronglai Shen, Nikolaus Schultz, 2011, PloS one.

Erratum: Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles (Cell Reports (2017) 18(11) (2780–2794) (S2211124717302140) (10.1016/j.celrep.2017.02.033))

Steven J. M. Jones, Chris Sander, Li Ding, 2017 .

Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens.

Ronglai Shen, Arul M Chinnaiyan, Mark A Rubin, 2002, The American journal of pathology.

Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.

Ronglai Shen, Arul M Chinnaiyan, Matthias D Hofer, 2004, Neoplasia.

Predictive Performance of Microarray Gene Signatures: Impact of Tumor Heterogeneity and Multiple Mechanisms of Drug Resistance

Christophe Lemetre, Ronglai Shen, Charles Swanton, 2014 .

A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers

Ronglai Shen, David Ferry, Paul Frewer, 2017, Clinical Cancer Research.

Autoantibody Signatures in Prostate Cancer

Jianjun Yu, Debashis Ghosh, Ronglai Shen, 2006 .

Breast Cancer Methylomes Establish an Epigenomic Foundation for Metastasis

Fang Fang, Ronglai Shen, Qianxing Mo, 2011, Science Translational Medicine.

Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis.

Debashis Ghosh, Lei Ding, Ronglai Shen, 2005, Cancer research.

Rationale for co-targeting IGF-1R and ALK in ALK fusion positive lung cancer

William Pao, Zhongming Zhao, Ronglai Shen, 2014, Nature Medicine.

Decreased α-Methylacyl CoA Racemase Expression in Localized Prostate Cancer is Associated with an Increased Rate of Biochemical Recurrence and Cancer-Specific Death

Debashis Ghosh, Ronglai Shen, Mark A. Rubin, 2005, Cancer Epidemiology Biomarkers & Prevention.